Improving Familial Hypercholesterolaemia Detection in Primary Care

From 14 October 2025 12:00 until 14 October 2025 13:00
Categories: Events

Familial hypercholesterolaemia (FH) is a common inherited condition, yet it often goes undiagnosed, leaving patients at significantly increased risk of premature cardiovascular disease. Early identification is key - and that’s where FAMCAT2 comes in.

Developed and deployed by colleagues at the University of Nottingham, FAMCAT2 is a validated clinical algorithm that uses routinely collected primary care data to identify individuals at increased risk of FH. By ranking patients based on their likelihood of having the condition, FAMCAT2 improves the precision of FH risk identification, helping to:

  • Detect more patients with undiagnosed FH
  • Reduce unnecessary referrals to genetic services
  • Enable localities to prioritise those who would benefit most from further assessment.


This free webinar will be led by experts from the University of Nottingham, including PRIMIS, who were directly involved in the development, validation, and deployment of the algorithm, alongside practitioners who have successfully implemented FAMCAT2 within their localities.

 

What you’ll learn:

  • The impact of FAMCAT2 on patient outcomes and service efficiency
  • How FAMCAT2 works and options for integration with existing primary care systems
  • Real-world insights from its implementation in early adopter sites
  • Practical tips for embedding FAMCAT2 into everyday primary care practice.

 


Who should attend:

This session is ideal for GPs, practice nurses, pharmacists, PCN leads, cardiovascular risk specialists, and anyone involved in improving the detection and management of FH.

Join us to gain practical insights into using FAMCAT2 to transform FH detection and improve patient outcomes.

 

Find out more and register to attend here.